8561-07193 Screening compound: 4-{2-[3-phenethyl-3,4-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-1(2H)-yl]ethyl}morpholine

8561-07193 Screening compound: 4-{2-[3-phenethyl-3,4-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-1(2H)-yl]ethyl}morpholine
8561-07193 Screening compound: 4-{2-[3-phenethyl-3,4-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-1(2H)-yl]ethyl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound 8561-07193
4-{2-[3-phenethyl-3,4-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-1(2H)-yl]ethyl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8561-07193

Molecular Formula

C23H29N5O (C23 H29 N5 O)

Compound Name

4-{2-[3-phenethyl-3,4-dihydro[1,3,5]triazino[1,2-a][1,3]benzimidazol-1(2H)-yl]ethyl}morpholine

IUPAC name

10-[2-(morpholin-4-yl)ethyl]-12-(2-phenylethyl)-181012-tetraazatricyclo[7.4.0.0^{27}]trideca-2468-tetraene

SMILES

C(CN1CN(CCN2CCOCC2)c2nc(cccc3)c3n2C1)c1ccccc1

InChI

InChI=1S/C23H29N5O/c1-2-6-20(7-3-1)10-11-26-18-27(13-12-25-14-16-29-17-15-25)23-24-21-8-4-5-9-22(21)28(23)19-26/h1-9H,10-19H2

InChI Key

ADCCLQPJVIDXGR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06754942

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

391.52

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.790

Distribution Coefficient, logD

1.701

Water Solubility, LogSw

-4.02

Polar Surface Area

29.597

Acid Dissociation Constant (pKa)

23.70

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

8561-07193 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Nucleic Acid Ligands (8311 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 8561-07193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8561-07193?
Check Price and Availability of 8561-07193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8561-07193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8561-07193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8561-07193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8561-07193 available by request